Latest from LabTalk

Harriet Fear profileHarriet Fear, CEO One Nucleus, discusses AstraZeneca and the Cambridge ecosystem
Read Harriet's blog post

Mark W profile picMark Wigglesworth, Director High Throughput Screening, talks about AZ’s plans for a world leading Lead Discovery centre in Cambridge, UK
Read Mark's blog post

AstraZeneca in the UK

Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that.

AstraZeneca is a major contributor to UK science and innovation investment, economic prosperity and to patient health.